Page 37 - Everstone Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Italian baking major Grupo Bimbo snaps up Modern Foods from Everstone Everstone in a statement on Wednesday said that Modern Food Enterprises, which was held by its bread and bakery platform Everfoods Asia, was sold to Ready Roti India, the domestic subsidiary of the Italian major. Private equity player Everstone Capital has sold Modern Foods, which it had taken over in early 2016 from Hindustan Unilever, to Italian baking major Grupo Bimbo for an undisclosed sum. Everstone in a statement on Wednesday said that Modern Food Enterprises, which was held by its bread and bakery platform Everfoods...

Correction: Global Synergy Acquisition Corp. Announces Closing of $258,750,000 Initial Public Offering January 12, 2021 23:58 ET | Source: Global Synergy Acquisition Corp. Global Synergy Acquisition Corp. NEW YORK, NY, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Global Synergy Acquisition Corp. (Nasdaq: GSAQU) (“GSAC” or the “Company”) announced today the closing of its initial public offering (“IPO”) of 25,875,000 units, including 3,375,000 units issued to the underwriters upon the full exercise of their over-allotment option, at a price to the public of $10.00 p...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Global Synergy Acquisition Corp. Announces Pricing of $225,000,000 Initial Public Offering Global Synergy Acquisition Corp.January 8, 2021 GMT NEW YORK, NY., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Global Synergy Acquisition Corp. (“GSAC” or the “Company”) announced today that it priced its initial public offering of 22,500,000 units at a price of $10.00 per unit. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and will trade under the ticker symbol “GSAQU” beginning Janua...

Senior Editor Princeton, N. J.-based Slayback Pharma is shoring up its generics and specialty pipeline. The company on Wednesday announced that The Everstone Group is investing up to $50 million in Series B funding. The new capital will be used to expand and accelerate further Slayback's pipeline of complex generic and specialty pharmaceutical products, Slayback said. In addition to the investment, Everstone managing directors Arjun Oberoi and Puncham Mukim will join Slayback's board of directors. Everstone joins existing institutional investor KKR, who first invested in Slaybac...